Influenza is often underestimated because it is often considered merely ordinary coughs and colds. In fact the influenza virus can cause disease
Severe and even death.
Influenza or flu is an infectious disease caused by a virus. Each year, 50-10 percent of the adult population and 20-30 percent of the population of children with influenza.
Influenza can be recognized by the occurrence of high fever (39-40 degrees Celsius), headaches, severe cough, extreme fatigue or aches.
Unlike ordinary coughs colds, influenza can cause dangerous diseases and complications that threaten the lives of many people.
Annual influenza epidemics cause approximately 3 million cases of disease severity and causes 250-500 thousand deaths worldwide.
Annual vaccination is the most effective way to prevent influenza infection and complications resulting from it.
"Unfortunately, many Indonesian people who do not know that we need the influenza vaccine each year. In fact, doctors sometimes even less understood this," said Prof. Dr. Samsuridjal Djauzi, dr, Sp.PD, Division of Allergy-Clinical Immunology Department of Internal Medicine FKUI-RSCM, in the event the symposium 'Current Situation and Prevention Influenza' at Hotel Borobudur, Jakarta, Saturday (05/06/2010).
Influenza can lead to secondary infections and exacerbations of chronic medical conditions that already exist, which causes severe complications such as acute otitis media and pneumonia, exacerbation of asthma and COPD (Chronic Obstructive Pulmonary Disease), increasing the risk of cardiovascular events, decline in kidney function, and aggravate the diabetic condition .
Some population groups have a higher risk of morbidity and mortality from influenza:
In both age groups are vulnerable:
1. Children with less than 2 years of age are the group with the risk of complications and hospitalization is higher compared with other age groups.
2. More than 90 percent of deaths from influenza occur in the age group 65 years or older.
Patients with concomitant diseases:
1. With cardiovascular disease, 50 times larger
2. With pulmonary disease, more than 100 times larger
3. With two or more of the accompanying diseases, more than 100 times larger
"In addition to healthy habits, prevention of influenza vaccination is most effective," said Prof. Cissy B. Kartasasmita, dr., Sp.A (K), MSc, PhD, Professor of Health Sciences
Children UNPAD and lung and airway expert Dr Hasan Sadikin children, Bandung.
Influenza vaccination provides significant advantages for high-risk population groups, namely:
1. Children
Vaccination in children showed the effectiveness of 77-91 percent to prevent the symptoms from influenza, morbidity due to influenza virus type A
2. Longevity
Vaccination proved to reduce the number of hospitalization from influenza pneumonia san at 27-34 percent.
3. Patients with asthma
In children with asthma conditions. Influenza vaccination is shown to decrease 22-41 percent of acute asthma exacerbations during the influenza season.
4. Patients with diabetes
Influenza vaccination is shown to decrease hospitalization rates for all complications or mortality rate of 72 percent in patients with diabetes for 18-64 years of age.
5. COPD Patients
Influenza vaccination proved effective to reduce exacerbations in patients with mild to severe COPD by 60-75 percent.
6. Cardiovascular patients
In pasein with a history of cardiovascular disease, influenza vaccination reduced the incidence of stroke daoat to 55 percent and reduced the incidence of myocardial infarction by 67 percent.
WHO has set a clear goal for pushing to increase vaccination coverage for high-risk population groups and to achieve vaccination coverage for 75 percent of the elderly population in the year 2010.
Currently ACIP (Advisory Committee on Immunization Practices) recommends the extension of the influenza vaccination to all influenza season.
"In Indonesia alone, influenza vaccination is still not made a national program, possibly next year. The new immunization existing Haemophilus influenzae type B (Hib)," said Prof. Dr. S. Sri Endang Rezeki Hadinegoro, dr., Sp.A (K), Division of Infectious and Tropical Diseases Department of Health Children FKUI-RSCM.